Abstract
Patients with type 2 diabetes have high levels of malondialdehyde (MDA), and clinical data suggest a reducing effect of rosiglitazone (RSG) on the level of MDA in these patients. However,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have